Indiana Officially Designated as the Radiopharmaceutical Capital of the World®
National designation reinforces Indiana’s global leadership in radiopharmaceutical innovation, manufacturing, and supply chain infrastructure. INDIANAPOLIS (July 21, 2025) — Indiana has secured the title of Radiopharmaceutical Capital of the World® from the U.S. Patent and Trademark Office, solidifying the state's global leadership in the rapidly growing field of precision medicine. Powered by a robust and highly specialized talent pool, unmatched logistics infrastructure, world-class research institutions, and geographically central location, Indiana serves as a critical nucleus for the rapidly growing radiopharmaceutical sector that is transforming oncology for patients and providers. Radiopharmaceuticals are drugs that contain, among other ingredients, radioisotopes. Depending on the type of radiation those radioisotopes produce, they can be used to diagnose or treat several medical conditions, including cancer and hyperthyroidism. Beyond its deep FDA-savvy talent pool, Indiana’s radiopharmaceutical leadership is anchored by specialized isotope production facilities, integrated [...]
